Reelin-mediated signaling in neuropsychiatric and neurodegenerative diseases

Progress in Neurobiology

Volumn 91, Issue 4, 2010, Pages 257-274

  Knuesel, Irene ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Alzheimer's disease; Cognitive impairments; Cytokines; In utero infection; Inflammation; Mid and late gestation; Polyriboinosinic polyribocytodilic acid; Schizophrenia

Indexed keywords

AMPA RECEPTOR; AMYLOID PRECURSOR PROTEIN; APOENZYME; CYTOKINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROTRANSMITTER; REELIN; NERVE CELL ADHESION MOLECULE; NERVE PROTEIN; REELIN PROTEIN; SCLEROPROTEIN; SERINE PROTEINASE;

ADULTHOOD; AGING; ALZHEIMER DISEASE; BRAIN; BRAIN DEVELOPMENT; CELL ADHESION; CELL LOSS; CHRONIC INFLAMMATION; COMORBIDITY; DEGENERATIVE DISEASE; DEVELOPMENTAL DISORDER; DISEASE COURSE; ENCEPHALITIS; GENETIC CODE; HUMAN; IMMATURITY; IMMUNE SYSTEM; IMMUNITY; MENTAL DETERIORATION; NERVE CELL; NERVE CELL DIFFERENTIATION; NERVE CELL PLASTICITY; NERVE FUNCTION; NEUROPATHOLOGY; NEUROPSYCHIATRY; OPEN READING FRAME; PATHOGENESIS; PREGNANCY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEGRADATION; REVIEW; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; ANIMAL; BIOLOGICAL MODEL; MENTAL DISEASE; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; BRAIN; CELL ADHESION MOLECULES, NEURONAL; EXTRACELLULAR MATRIX PROTEINS; HUMANS; MENTAL DISORDERS; MODELS, BIOLOGICAL; NERVE TISSUE PROTEINS; NEURODEGENERATIVE DISEASES; SERINE ENDOPEPTIDASES; SIGNAL TRANSDUCTION;

EID: 77954203843     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2010.04.002     Document Type: Review

References (253)

1. Abdolmaleky H.M., Cheng K.H., Russo A., Smith C.L., Faraone S.V., Wilcox M., Shafa R., Glatt S.J., Nguyen G., Ponte J.F., Thiagalingam S., Tsuang M.T. Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: a preliminary report. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2005, 134:60-66.
2. Abraham H., Meyer G. Reelin-expressing neurons in the postnatal and adult human hippocampal formation. Hippocampus 2003, 13:715-727.
3. Abraham H., Perez-Garcia C.G., Meyer G. p73 and Reelin in Cajal-Retzius cells of the developing human hippocampal formation. Cereb. Cortex 2004, 14:484-495.
4. Akahane A., Kunugi H., Tanaka H., Nanko S. Association analysis of polymorphic CGG repeat in 5' UTR of the reelin and VLDLR genes with schizophrenia. Schizophr. Res. 2002, 58:37-41.
5. Alcantara S., Ruiz M., D'Arcangelo G., Ezan F., de Lecea L., Curran T., Sotelo C., Soriano E. Regional and cellular patterns of reelin mRNA expression in the forebrain of the developing and adult mouse. J. Neurosci. 1998, 18:7779-7799.
6. Alexopoulou L., Holt A.C., Medzhitov R., Flavell R.A. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001, 413:732-738.
7. Arnaud L., Ballif B.A., Cooper J.A. Regulation of protein tyrosine kinase signaling by substrate degradation during brain development. Mol. Cell. Biol. 2003, 23:9293-9302.
8. Arnaud L., Ballif B.A., Forster E., Cooper J.A. Fyn tyrosine kinase is a critical regulator of disabled-1 during brain development. Curr. Biol. 2003, 13:9-17.
9. Arnold S.E. Neurodevelopmental abnormalities in schizophrenia: insights from neuropathology. Dev. Psychopathol. 1999, 11:439-456.
10. Arnold S.E., Trojanowski J.Q., Gur R.E., Blackwell P., Han L.Y., Choi C. Absence of neurodegeneration and neural injury in the cerebral cortex in a sample of elderly patients with schizophrenia. Arch. Gen. Psychiatry 1998, 55:225-232.
11. Assadi A.H., Zhang G., Beffert U., McNeil R.S., Renfro A.L., Niu S., Quattrocchi C.C., Antalffy B.A., Sheldon M., Armstrong D.D., Wynshaw-Boris A., Herz J., D'Arcangelo G., Clark G.D. Interaction of reelin signaling and Lis1 in brain development. Nat. Genet. 2003, 35:270-276.
12. Ballif B.A., Arnaud L., Cooper J.A. Tyrosine phosphorylation of Disabled-1 is essential for Reelin-stimulated activation of Akt and Src family kinases. Brain Res. Mol. Brain Res. 2003, 117:152-159.
13. Ballif B.A., Arnaud L., Arthur W.T., Guris D., Imamoto A., Cooper J.A. Activation of a Dab1/CrkL/C3G/Rap1 pathway in Reelin-stimulated neurons. Curr. Biol. 2004, 14:606-610.
14. Baloyannis S.J. Morphological and morphometric alterations of Cajal-Retzius cells in early cases of Alzheimer's disease: a Golgi and electron microscope study. Int. J. Neurosci. 2005, 115:965-980.
15. Barr A.M., Fish K.N., Markou A. The reelin receptors VLDLR and ApoER2 regulate sensorimotor gating in mice. Neuropharmacology 2007, 52:1114-1123.
16. Beffert U., Morfini G., Bock H.H., Reyna H., Brady S.T., Herz J. Reelin-mediated signaling locally regulates protein kinase B/Akt and glycogen synthase kinase 3beta. J. Biol. Chem. 2002, 277:49958-49964.
17. Beffert U., Weeber E.J., Morfini G., Ko J., Brady S.T., Tsai L.H., Sweatt J.D., Herz J. Reelin and cyclin-dependent kinase 5-dependent signals cooperate in regulating neuronal migration and synaptic transmission. J. Neurosci. 2004, 24:1897-1906.
18. Beffert U., Durudas A., Weeber E.J., Stolt P.C., Giehl K.M., Sweatt J.D., Hammer R.E., Herz J. Functional dissection of Reelin signaling by site-directed disruption of Disabled-1 adaptor binding to apolipoprotein E receptor 2: distinct roles in development and synaptic plasticity. J. Neurosci. 2006, 26:2041-2052.
19. Beffert U., Weeber E.J., Durudas A., Qiu S., Masiulis I., Sweatt J.D., Li W.P., Adelmann G., Frotscher M., Hammer R.E., Herz J. Modulation of synaptic plasticity and memory by Reelin involves differential splicing of the lipoprotein receptor Apoer2. Neuron 2005, 47:567-579.
20. Belinson H., Michaelson D.M. Pathological synergism between amyloid-beta and apolipoprotein E4 - the most prevalent yet understudied genetic risk factor for Alzheimer's disease. J. Alzheimers Dis. 2009, 17:469-481.
21. Belvindrah R., Graus-Porta D., Goebbels S., Nave K.A., Muller U. Beta1 integrins in radial glia but not in migrating neurons are essential for the formation of cell layers in the cerebral cortex. J. Neurosci. 2007, 27:13854-13865.
22. Bertram L., Tanzi R.E. Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses. Nat. Rev. Neurosci. 2008, 9:768-778.
23. Biber K., Zuurman M.W., Dijkstra I.M., Boddeke H.W. Chemokines in the brain: neuroimmunology and beyond. Curr. Opin. Pharmacol. 2002, 2:63-68.
24. Blackwood D.H., Fordyce A., Walker M.T., St Clair D.M., Porteous D.J., Muir W.J. Schizophrenia and affective disorders - cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family. Am. J. Hum. Genet. 2001, 69:428-433.
25. Bock H.H., Herz J. Reelin activates SRC family tyrosine kinases in neurons. Curr. Biol. 2003, 13:18-26.
26. Bock H.H., Jossin Y., May P., Bergner O., Herz J. Apolipoprotein E receptors are required for reelin-induced proteasomal degradation of the neuronal adaptor protein Disabled-1. J. Biol. Chem. 2004, 279:33471-33479.
27. Bock H.H., Jossin Y., Liu P., Forster E., May P., Goffinet A.M., Herz J. Phosphatidylinositol 3-kinase interacts with the adaptor protein Dab1 in response to Reelin signaling and is required for normal cortical lamination. J. Biol. Chem. 2003, 278:38772-38779.
28. Boksa P. Maternal infection during pregnancy and schizophrenia. J. Psychiatry Neurosci. 2008, 33:183-185.
29. Bookheimer S., Burggren A. APOE-4 genotype and neurophysiological vulnerability to Alzheimer's and cognitive aging. Annu. Rev. Clin. Psychol. 2009, 5:343-362.
30. Borrell V., Pujadas L., Simo S., Dura D., Sole M., Cooper J.A., Del Rio J.A., Soriano E. Reelin and mDab1 regulate the development of hippocampal connections. Mol. Cell. Neurosci. 2007, 36:158-173.
31. Borrell V., Del Rio J.A., Alcantara S., Derer M., Martinez A., D'Arcangelo G., Nakajima K., Mikoshiba K., Derer P., Curran T., Soriano E. Reelin regulates the development and synaptogenesis of the layer-specific entorhino-hippocampal connections. J. Neurosci. 1999, 19:1345-1358.
32. Botella-Lopez A., Cuchillo-Ibanez I., Cotrufo T., Mok S.S., Li Q.X., Barquero M.S., Dierssen M., Soriano E., Saez-Valero J. Beta-amyloid controls altered Reelin expression and processing in Alzheimer's disease. Neurobiol. Dis. 2009, 37:682-691.
33. Botella-Lopez A., Burgaya F., Gavin R., Garcia-Ayllon M.S., Gomez-Tortosa E., Pena-Casanova J., Urena J.M., Del Rio J.A., Blesa R., Soriano E., Saez-Valero J. Reelin expression and glycosylation patterns are altered in Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:5573-5578.
34. Boyles J.K., Pitas R.E., Wilson E., Mahley R.W., Taylor J.M. Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J. Clin. Invest. 1985, 76:1501-1513.
35. Brask J., Kristensson K., Hill R.H. Exposure to interferon-gamma during synaptogenesis increases inhibitory activity after a latent period in cultured rat hippocampal neurons. Eur. J. Neurosci. 2004, 19:3193-3201.
36. Brown A.S. Prenatal infection as a risk factor for schizophrenia. Schizophr. Bull. 2006, 32:200-202.
37. Buchhave P., Zetterberg H., Blennow K., Minthon L., Janciauskiene S., Hansson O. Soluble TNF receptors are associated with Abeta metabolism and conversion to dementia in subjects with mild cognitive impairment. Neurobiol. Aging 2008.
38. Buhl L., Bojsen-Moller M. Frequency of Alzheimer's disease in a postmortem study of psychiatric patients. Dan. Med. Bull. 1988, 35:288-290.
39. Campo C.G., Sinagra M., Verrier D., Manzoni O.J., Chavis P. Reelin secreted by GABAergic neurons regulates glutamate receptor homeostasis. PLoS ONE 2009, 4:e5505.
40. Chai X., Forster E., Zhao S., Bock H.H., Frotscher M. Reelin stabilizes the actin cytoskeleton of neuronal processes by inducing n-cofilin phosphorylation at serine3. J. Neurosci. 2009, 29:288-299.
41. Chen K., Ochalski P.G., Tran T.S., Sahir N., Schubert M., Pramatarova A., Howell B.W. Interaction between Dab1 and CrkII is promoted by Reelin signaling. J. Cell Sci. 2004, 117:4527-4536.
42. Chen M.L., Chen S.Y., Huang C.H., Chen C.H. Identification of a single nucleotide polymorphism at the 5' promoter region of human reelin gene and association study with schizophrenia. Mol. Psychiatry 2002, 7:447-448.
43. Chen Y., Beffert U., Ertunc M., Tang T.S., Kavalali E.T., Bezprozvanny I., Herz J. Reelin modulates NMDA receptor activity in cortical neurons. J. Neurosci. 2005, 25:8209-8216.
44. Chin J., Massaro C.M., Palop J.J., Thwin M.T., Yu G.Q., Bien-Ly N., Bender A., Mucke L. Reelin depletion in the entorhinal cortex of human amyloid precursor protein transgenic mice and humans with Alzheimer's disease. J. Neurosci. 2007, 27:2727-2733.
45. Cooper J.A. A mechanism for inside-out lamination in the neocortex. Trends Neurosci. 2008, 31:113-119.
46. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., Pericak-Vance M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993, 261:921-923.
47. Costa E., Davis J., Grayson D.R., Guidotti A., Pappas G.D., Pesold C. Dendritic spine hypoplasticity and downregulation of reelin and GABAergic tone in schizophrenia vulnerability. Neurobiol. Dis. 2001, 8:723-742.
48. Costa E., Grayson D.R., Mitchell C.P., Tremolizzo L., Veldic M., Guidotti A. GABAergic cortical neuron chromatin as a putative target to treat schizophrenia vulnerability. Crit. Rev. Neurobiol. 2003, 15:121-142.
49. Curran T., D'Arcangelo G. Role of reelin in the control of brain development. Brain Res. Brain Res. Rev. 1998, 26:285-294.
50. D'Arcangelo G., Miao G.G., Chen S.C., Soares H.D., Morgan J.I., Curran T. A protein related to extracellular matrix proteins deleted in the mouse mutant reeler. Nature 1995, 374:719-723.
51. D'Arcangelo G., Homayouni R., Keshvara L., Rice D.S., Sheldon M., Curran T. Reelin is a ligand for lipoprotein receptors. Neuron 1999, 24:471-479.
52. de Bergeyck V., Nakajima K., Lambert de Rouvroit C., Naerhuyzen B., Goffinet A.M., Miyata T., Ogawa M., Mikoshiba K. A truncated Reelin protein is produced but not secreted in the'Orleans' reeler mutation (Reln[rl-Orl]). Brain Res. Mol. Brain Res. 1997, 50:85-90.
53. Deguchi K., Inoue K., Avila W.E., Lopez-Terrada D., Antalffy B.A., Quattrocchi C.C., Sheldon M., Mikoshiba K., D'Arcangelo G., Armstrong D.L. Reelin and disabled-1 expression in developing and mature human cortical neurons. J. Neuropathol. Exp. Neurol. 2003, 62:676-684.
54. Del Rio J.A., Heimrich B., Borrell V., Forster E., Drakew A., Alcantara S., Nakajima K., Miyata T., Ogawa M., Mikoshiba K., Derer P., Frotscher M., Soriano E. A role for Cajal-Retzius cells and reelin in the development of hippocampal connections. Nature 1997, 385:70-74.
55. Derer P., Derer M., Goffinet A. Axonal secretion of Reelin by Cajal-Retzius cells: evidence from comparison of normal and Reln(Orl) mutant mice. J. Comp. Neurol. 2001, 440:136-143.
56. Dergunov A.D. Role of ApoE in conformation-prone diseases and atherosclerosis. Biochemistry (Mosc.) 2006, 71:707-712.
57. DeSilva U., D'Arcangelo G., Braden V.V., Chen J., Miao G.G., Curran T., Green E.D. The human reelin gene: isolation, sequencing, and mapping on chromosome 7. Genome Res. 1997, 7:157-164.
58. DesJarlais R.L., Seibel G.L., Kuntz I.D., Furth P.S., Alvarez J.C., Ortiz de Montellano P.R., DeCamp D.L., Babe L.M., Craik C.S. Structure-based design of nonpeptide inhibitors specific for the human immunodeficiency virus 1 protease. Proc. Natl. Acad. Sci. U.S.A. 1990, 87:6644-6648.
59. Devanand D.P., Jacobs D.M., Tang M.X., Del Castillo-Castaneda C., Sano M., Marder K., Bell K., Bylsma F.W., Brandt J., Albert M., Stern Y. The course of psychopathologic features in mild to moderate Alzheimer disease. Arch. Gen. Psychiatry 1997, 54:257-263.
60. Doehner J., Madhusudan A., Konietzko U., Fritschy J.M., Knuesel I. Co-localization of Reelin and proteolytic APP fragments in hippocampal plaques in aged wild type mice. J. Alzheimers Dis. 2010, 19:1339-1357.
61. Dong E., Guidotti A., Grayson D.R., Costa E. Histone hyperacetylation induces demethylation of reelin and 67-kDa glutamic acid decarboxylase promoters. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:4676-4681.
62. Dong E., Nelson M., Grayson D.R., Costa E., Guidotti A. Clozapine and sulpiride but not haloperidol or olanzapine activate brain DNA demethylation. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:13614-13619.
63. Dong E., Caruncho H., Liu W.S., Smalheiser N.R., Grayson D.R., Costa E., Guidotti A. A reelin-integrin receptor interaction regulates Arc mRNA translation in synaptoneurosomes. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:5479-5484.
64. Duit S., Mayer H., Blake S.M., Schneider W.J., Nimpf J. Differential functions of ApoER2 and very low density lipoprotein receptor in Reelin signaling depend on differential sorting of the receptors. J. Biol. Chem. 2010, 285:4896-4908.
65. Dulabon L., Olson E.C., Taglienti M.G., Eisenhuth S., McGrath B., Walsh C.A., Kreidberg J.A., Anton E.S. Reelin binds alpha3beta1 integrin and inhibits neuronal migration. Neuron 2000, 27:33-44.
66. Dwork A.J., Susser E.S., Keilp J., Waniek C., Liu D., Kaufman M., Zemishlany Z., Prohovnik I. Senile degeneration and cognitive impairment in chronic schizophrenia. Am. J. Psychiatry 1998, 155:1536-1543.
67. Eastwood S.L., Harrison P.J. Interstitial white matter neurons express less reelin and are abnormally distributed in schizophrenia: towards an integration of molecular and morphologic aspects of the neurodevelopmental hypothesis. Mol. Psychiatry 2003, 8. pp. 769, 821-731.
68. Eastwood S.L., Harrison P.J. Cellular basis of reduced cortical reelin expression in schizophrenia. Am. J. Psychiatry 2006, 163:540-542.
69. Eastwood S.L., Law A.J., Everall I.P., Harrison P.J. The axonal chemorepellant semaphorin 3A is increased in the cerebellum in schizophrenia and may contribute to its synaptic pathology. Mol. Psychiatry 2003, 8:148-155.
70. Estus S., Golde T.E., Kunishita T., Blades D., Lowery D., Eisen M., Usiak M., Qu X.M., Tabira T., Greenberg B.D., et al. Potentially amyloidogenic, carboxyl-terminal derivatives of the amyloid protein precursor. Science 1992, 255:726-728.
71. Falconer D. Two new mutants, " trembler" and " reeler" , with neurological actions in the house mouse (Mus musculus L.). J. Génet. (Paris) 1951, 192-201.
72. Fatemi S.H., Earle J.A., McMenomy T. Reduction in Reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression. Mol. Psychiatry 2000, 5:654-663.
73. Fatemi S.H., Kroll J.L., Stary J.M. Altered levels of Reelin and its isoforms in schizophrenia and mood disorders. Neuroreport 2001, 12:3209-3215.
74. Fatemi S.H., Stary J.M., Earle J.A., Araghi-Niknam M., Eagan E. GABAergic dysfunction in schizophrenia and mood disorders as reflected by decreased levels of glutamic acid decarboxylase 65 and 67kDa and Reelin proteins in cerebellum. Schizophr. Res. 2005, 72:109-122.
75. Feng L., Cooper J.A. Dual functions of Dab1 during brain development. Mol. Cell. Biol. 2009, 29:324-332.
76. Frotscher M. Cajal-Retzius cells, Reelin, and the formation of layers. Curr. Opin. Neurobiol. 1998, 8:570-575.
77. Frotscher M., Zhao S., Forster E. Development of cell and fiber layers in the dentate gyrus. Prog. Brain Res. 2007, 163:133-142.
78. Frotscher M., Chai X., Bock H.H., Haas C.A., Forster E., Zhao S. Role of Reelin in the development and maintenance of cortical lamination. J. Neural Transm. 2009, 116:1451-1455.
79. Furukawa K., Sopher B.L., Rydel R.E., Begley J.G., Pham D.G., Martin G.M., Fox M., Mattson M.P. Increased activity-regulating and neuroprotective efficacy of alpha-secretase-derived secreted amyloid precursor protein conferred by a C-terminal heparin-binding domain. J. Neurochem. 1996, 67:1882-1896.
80. Gao Y., Pimplikar S.W. The gamma-secretase-cleaved C-terminal fragment of amyloid precursor protein mediates signaling to the nucleus. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:14979-14984.
81. Giunta B., Fernandez F., Nikolic W.V., Obregon D., Rrapo E., Town T., Tan J. Inflammaging as a prodrome to Alzheimer's disease. J. Neuroinflammation 2008, 5:51.
82. Glantz L.A., Gilmore J.H., Lieberman J.A., Jarskog L.F. Apoptotic mechanisms and the synaptic pathology of schizophrenia. Schizophr. Res. 2006, 81:47-63.
83. Glenner G.G., Wong C.W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 1984, 120:885-890.
84. Goate A., Chartier-Harlin M.C., Mullan M., Brown J., Crawford F., Fidani L., Giuffra L., Haynes A., Irving N., James L., et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991, 349:704-706.
85. Goldberger C., Gourion D., Leroy S., Schurhoff F., Bourdel M.C., Leboyer M., Krebs M.O. Population-based and family-based association study of 5'UTR polymorphism of the reelin gene and schizophrenia. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2005, 137B:51-55.
86. Gotthardt M., Trommsdorff M., Nevitt M.F., Shelton J., Richardson J.A., Stockinger W., Nimpf J., Herz J. Interactions of the low density lipoprotein receptor gene family with cytosolic adaptor and scaffold proteins suggest diverse biological functions in cellular communication and signal transduction. J. Biol. Chem. 2000, 275:25616-25624.
87. Grayson D.R., Jia X., Chen Y., Sharma R.P., Mitchell C.P., Guidotti A., Costa E. Reelin promoter hypermethylation in schizophrenia. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:9341-9346.
88. Gregorio S.P., Sallet P.C., Do K.A., Lin E., Gattaz W.F., Dias-Neto E. Polymorphisms in genes involved in neurodevelopment may be associated with altered brain morphology in schizophrenia: preliminary evidence. Psychiatry Res. 2009, 165:1-9.
89. Griffin W.S., Liu L., Li Y., Mrak R.E., Barger S.W. Interleukin-1 mediates Alzheimer and Lewy body pathologies. J. Neuroinflammation 2006, 3:5.
90. Groc L., Choquet D., Stephenson F.A., Verrier D., Manzoni O.J., Chavis P. NMDA receptor surface trafficking and synaptic subunit composition are developmentally regulated by the extracellular matrix protein Reelin. J. Neurosci. 2007, 27:10165-10175.
91. Grundke-Iqbal I., Iqbal K., Tung Y.C., Quinlan M., Wisniewski H.M., Binder L.I. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc. Natl. Acad. Sci. U.S.A. 1986, 83:4913-4917.
92. Guidotti A., Pesold C., Costa E. New neurochemical markers for psychosis: a working hypothesis of their operation. Neurochem. Res. 2000, 25:1207-1218.
93. Guidotti A., Ruzicka W., Grayson D.R., Veldic M., Pinna G., Davis J.M., Costa E. S-adenosyl methionine and DNA methyltransferase-1 mRNA overexpression in psychosis. Neuroreport 2007, 18:57-60.
94. Guidotti A., Auta J., Davis J.M., Di-Giorgi-Gerevini V., Dwivedi Y., Grayson D.R., Impagnatiello F., Pandey G., Pesold C., Sharma R., Uzunov D., Costa E. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch. Gen. Psychiatry 2000, 57:1061-1069.
95. Haas C.A., Dudeck O., Kirsch M., Huszka C., Kann G., Pollak S., Zentner J., Frotscher M. Role for reelin in the development of granule cell dispersion in temporal lobe epilepsy. J. Neurosci. 2002, 22:5797-5802.
96. Haass C., Koo E.H., Mellon A., Hung A.Y., Selkoe D.J. Targeting of cell-surface beta-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments. Nature 1992, 357:500-503.
97. Hack I., Hellwig S., Junghans D., Brunne B., Bock H.H., Zhao S., Frotscher M. Divergent roles of ApoER2 and Vldlr in the migration of cortical neurons. Development 2007, 134:3883-3891.
98. Hamburgh M. Analysis of the postnatal developmental effects of " Reeler" a neurological mutation in mice. A study in developmental genetics. Dev. Biol. 1963, 19:165-185.
99. Harrison P.J. Schizophrenia: a disorder of neurodevelopment?. Curr. Opin. Neurobiol. 1997, 7:285-289.
100. Harrison P.J. The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 1999, 122(Pt 4):593-624.
101. Harrison P.J. Schizophrenia susceptibility genes and their neurodevelopmental implications: focus on neuregulin 1. Novartis Found. Symp. 2007, 288:246-255.
102. Harrison P.J., Weinberger D.R. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol. Psychiatry 2005, 10:40-68.
103. He P., Zhong Z., Lindholm K., Berning L., Lee W., Lemere C., Staufenbiel M., Li R., Shen Y. Deletion of tumor necrosis factor death receptor inhibits amyloid beta generation and prevents learning and memory deficits in Alzheimer's mice. J. Cell Biol. 2007, 178:829-841.
104. Heinrich C., Nitta N., Flubacher A., Muller M., Fahrner A., Kirsch M., Freiman T., Suzuki F., Depaulis A., Frotscher M., Haas C.A. Reelin deficiency and displacement of mature neurons, but not neurogenesis, underlie the formation of granule cell dispersion in the epileptic hippocampus. J. Neurosci. 2006, 26:4701-4713.
105. Hellstrom I.C., Danik M., Luheshi G.N., Williams S. Chronic LPS exposure produces changes in intrinsic membrane properties and a sustained IL-beta-dependent increase in GABAergic inhibition in hippocampal CA1 pyramidal neurons. Hippocampus 2005, 15:656-664.
106. Herz J., Chen Y. Reelin, lipoprotein receptors and synaptic plasticity. Nat. Rev. Neurosci. 2006, 7:850-859.
107. Hibi T., Hattori M. The N-terminal fragment of Reelin is generated after endocytosis and released through the pathway regulated by Rab11. FEBS Lett. 2009, 583:1299-1303.
108. Hiesberger T., Trommsdorff M., Howell B.W., Goffinet A., Mumby M.C., Cooper J.A., Herz J. Direct binding of Reelin to VLDL receptor and ApoE receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates tau phosphorylation. Neuron 1999, 24:481-489.
109. Higaki J., Murphy G.M., Cordell B. Inhibition of beta-amyloid formation by haloperidol: a possible mechanism for reduced frequency of Alzheimer's disease pathology in schizophrenia. J. Neurochem. 1997, 68:333-336.
110. Hirotsune S., Takahara T., Sasaki N., Hirose K., Yoshiki A., Ohashi T., Kusakabe M., Murakami Y., Muramatsu M., Watanabe S., et al. The reeler gene encodes a protein with an EGF-like motif expressed by pioneer neurons. Nat. Genet. 1995, 10:77-83.
111. Hoe H.S., Tran T.S., Matsuoka Y., Howell B.W., Rebeck G.W. Dab1 and Reelin effects on APP and ApoEr2 trafficking and processing. J. Biol. Chem. 2006, 281:35176-35185.
112. Hoe H.S., Pocivavsek A., Chakraborty G., Fu Z., Vicini S., Ehlers M.D., Rebeck G.W. Apolipoprotein E receptor 2 interactions with the N-methyl-D-aspartate receptor. J. Biol. Chem. 2006, 281:3425-3431.
113. Hoe H.S., Lee K.J., Carney R.S., Lee J., Markova A., Lee J.Y., Howell B.W., Hyman B.T., Pak D.T., Bu G., Rebeck G.W. Interaction of reelin with amyloid precursor protein promotes neurite outgrowth. J. Neurosci. 2009, 29:7459-7473.
114. Hollingworth P., Hamshere M.L., Moskvina V., Dowzell K., Moore P.J., Foy C., Archer N., Lynch A., Lovestone S., Brayne C., Rubinsztein D.C., Lawlor B., Gill M., Owen M.J., Williams J. Four components describe behavioral symptoms in 1,120 individuals with late-onset Alzheimer's disease. J. Am. Geriatr. Soc. 2006, 54:1348-1354.
115. Homayouni R., Rice D.S., Sheldon M., Curran T. Disabled-1 binds to the cytoplasmic domain of amyloid precursor-like protein 1. J. Neurosci. 1999, 19:7507-7515.
116. Hoozemans J.J., Veerhuis R., Rozemuller J.M., Eikelenboom P. Neuroinflammation and regeneration in the early stages of Alzheimer's disease pathology. Int. J. Dev. Neurosci. 2006, 24:157-165.
117. Howell B.W., Herrick T.M., Cooper J.A. Reelin-induced tryosine phosphorylation of disabled 1 during neuronal positioning. Genes Dev. 1999, 13:643-648.
118. Huang C.H., Chen C.H. Absence of association of a polymorphic GGC repeat at the 5' untranslated region of the reelin gene with schizophrenia. Psychiatry Res. 2006, 142:89-92.
119. Huang Y., Magdaleno S., Hopkins R., Slaughter C., Curran T., Keshvara L. Tyrosine phosphorylated Disabled 1 recruits Crk family adapter proteins. Biochem. Biophys. Res. Commun. 2004, 318:204-212.
120. Impagnatiello F., Guidotti A.R., Pesold C., Dwivedi Y., Caruncho H., Pisu M.G., Uzunov D.P., Smalheiser N.R., Davis J.M., Pandey G.N., Pappas G.D., Tueting P., Sharma R.P., Costa E. A decrease of reelin expression as a putative vulnerability factor in schizophrenia. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:15718-15723.
121. Jones A., Kulozik P., Ostertag A., Herzig S. Common pathological processes and transcriptional pathways in Alzheimer's disease and type 2 diabetes. J. Alzheimers Dis. 2009, 16:787-808.
122. Jossin Y., Gui L., Goffinet A.M. Processing of Reelin by embryonic neurons is important for function in tissue but not in dissociated cultured neurons. J. Neurosci. 2007, 27:4243-4252.
123. Jossin Y., Ogawa M., Metin C., Tissir F., Goffinet A.M. Inhibition of SRC family kinases and non-classical protein kinases C induce a reeler-like malformation of cortical plate development. J. Neurosci. 2003, 23:9953-9959.
124. Jossin Y., Ignatova N., Hiesberger T., Herz J., Lambert de Rouvroit C., Goffinet A.M. The central fragment of Reelin, generated by proteolytic processing in vivo, is critical to its function during cortical plate development. J. Neurosci. 2004, 24:514-521.
125. Kamiya A., Kubo K., Tomoda T., Takaki M., Youn R., Ozeki Y., Sawamura N., Park U., Kudo C., Okawa M., Ross C.A., Hatten M.E., Nakajima K., Sawa A. A schizophrenia-associated mutation of DISC1 perturbs cerebral cortex development. Nat. Cell Biol. 2005, 7:1167-1178.
126. Karim S., Burns A. The biology of psychosis in older people. J. Geriatr. Psychiatry Neurol. 2003, 16:207-212.
127. Kerjan G., Gleeson J.G. A missed exit: Reelin sets in motion Dab1 polyubiquitination to put the break on neuronal migration. Genes Dev. 2007, 21:2850-2854.
128. Kienlen-Campard P., Miolet S., Tasiaux B., Octave J.N. Intracellular amyloid-beta 1-42, but not extracellular soluble amyloid-beta peptides, induces neuronal apoptosis. J. Biol. Chem. 2002, 277:15666-15670.
129. Knable M.B., Barci B.M., Webster M.J., Meador-Woodruff J., Torrey E.F. Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium. Mol. Psychiatry 2004, 9:609-620.
130. Knobloch M., Farinelli M., Konietzko U., Nitsch R.M., Mansuy I.M. Abeta oligomer-mediated long-term potentiation impairment involves protein phosphatase 1-dependent mechanisms. J. Neurosci. 2007, 27:7648-7653.
131. Knuesel I., Nyffeler M., Mormede C., Muhia M., Meyer U., Pietropaolo S., Yee B.K., Pryce C.R., Laferla F.M., Marighetto A., Feldon J. Age-related accumulation of Reelin in amyloid-like deposits. Neurobiol. Aging 2009, 30:697-716.
132. Kobow K., Jeske I., Hildebrandt M., Hauke J., Hahnen E., Buslei R., Buchfelder M., Weigel D., Stefan H., Kasper B., Pauli E., Blumcke I. Increased reelin promoter methylation is associated with granule cell dispersion in human temporal lobe epilepsy. J. Neuropathol. Exp. Neurol. 2009, 68:356-364.
133. Kohno S., Kohno T., Nakano Y., Suzuki K., Ishii M., Tagami H., Baba A., Hattori M. Mechanism and significance of specific proteolytic cleavage of Reelin. Biochem. Biophys. Res. Commun. 2009, 380:93-97.
134. Kolomeets N.S., Orlovskaya D.D., Uranova N.A. Decreased numerical density of CA3 hippocampal mossy fiber synapses in schizophrenia. Synapse 2007, 61:615-621.
135. Kraepelin E. Psychiatry: A Textbook for Students and Physicians 1991, Science History Publications/USA, Canton, MA.
136. Krueger D.D., Howell J.L., Hebert B.F., Olausson P., Taylor J.R., Nairn A.C. Assessment of cognitive function in the heterozygous reeler mouse. Psychopharmacology (Berl.) 2006, 189:95-104.
137. Kubo K., Mikoshiba K., Nakajima K. Secreted Reelin molecules form homodimers. Neurosci. Res. 2002, 43:381-388.
138. Kundakovic M., Chen Y., Costa E., Grayson D.R. DNA methyltransferase inhibitors coordinately induce expression of the human reelin and glutamic acid decarboxylase 67 genes. Mol. Pharmacol. 2007, 71:644-653.
139. Kung L., Conley R., Chute D.J., Smialek J., Roberts R.C. Synaptic changes in the striatum of schizophrenic cases: a controlled postmortem ultrastructural study. Synapse 1998, 28:125-139.
140. Kuo G., Arnaud L., Kronstad-O'Brien P., Cooper J.A. Absence of Fyn and Src causes a reeler-like phenotype. J. Neurosci. 2005, 25:8578-8586.
141. Lacor P.N., Grayson D.R., Auta J., Sugaya I., Costa E., Guidotti A. Reelin secretion from glutamatergic neurons in culture is independent from neurotransmitter regulation. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:3556-3561.
142. Lambert de Rouvroit C., de Bergeyck V., Cortvrindt C., Bar I., Eeckhout Y., Goffinet A.M. Reelin, the extracellular matrix protein deficient in reeler mutant mice, is processed by a metalloproteinase. Exp. Neurol. 1999, 156:214-217.
143. Lambert M.P., Barlow A.K., Chromy B.A., Edwards C., Freed R., Liosatos M., Morgan T.E., Rozovsky I., Trommer B., Viola K.L., Wals P., Zhang C., Finch C.E., Krafft G.A., Klein W.L. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:6448-6453.
144. Lee S.J., Liyanage U., Bickel P.E., Xia W., Lansbury P.T., Kosik K.S. A detergent-insoluble membrane compartment contains A beta in vivo. Nat. Med. 1998, 4:730-734.
145. Levy-Lahad E., Wasco W., Poorkaj P., Romano D.M., Oshima J., Pettingell W.H., Yu C.E., Jondro P.D., Schmidt S.D., Wang K., et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 1995, 269:973-977.
146. Li R., Yang L., Lindholm K., Konishi Y., Yue X., Hampel H., Zhang D., Shen Y. Tumor necrosis factor death receptor signaling cascade is required for amyloid-beta protein-induced neuron death. J. Neurosci. 2004, 24:1760-1771.
147. Loup F., Picard F., Yonekawa Y., Wieser H.G., Fritschy J.M. Selective changes in GABAA receptor subtypes in white matter neurons of patients with focal epilepsy. Brain 2009, 132:2449-2463.
148. Loup F., Picard F., Andre V.M., Kehrli P., Yonekawa Y., Wieser H.G., Fritschy J.M. Altered expression of alpha3-containing GABAA receptors in the neocortex of patients with focal epilepsy. Brain 2006, 129:3277-3289.
149. Madhusudan A., Sidler C., Knuesel I. Accumulation of reelin-positive plaques is accompanied by a decline in basal forebrain projection neurons during normal aging. Eur. J. Neurosci. 2009, 30:1064-1076.
150. Maeda K., Sugino H., Hirose T., Kitagawa H., Nagai T., Mizoguchi H., Takuma K., Yamada K. Clozapine prevents a decrease in neurogenesis in mice repeatedly treated with phencyclidine. J. Pharmacol. Sci. 2007, 103:299-308.
151. Mariani J., Crepel F., Mikoshiba K., Changeux J.P., Sotelo C. Anatomical, physiological and biochemical studies of the cerebellum from Reeler mutant mouse. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 1977, 281:1-28.
152. McGeer P.L., McGeer E.G. Local neuroinflammation and the progression of Alzheimer's disease. J. Neurovirol. 2002, 8:529-538.
153. McGeer P.L., Schulzer M., McGeer E.G. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology 1996, 47:425-432.
154. McGrath J.J., Susser E.S. New directions in the epidemiology of schizophrenia. Med. J. Aust. 2009, 190:7-9.
155. Medeiros R., Prediger R.D., Passos G.F., Pandolfo P., Duarte F.S., Franco J.L., Dafre A.L., Di Giunta G., Figueiredo C.P., Takahashi R.N., Campos M.M., Calixto J.B. Connecting TNF-alpha signaling pathways to iNOS expression in a mouse model of Alzheimer's disease: relevance for the behavioral and synaptic deficits induced by amyloid beta protein. J. Neurosci. 2007, 27:5394-5404.
156. Meeks T.W., Ropacki S.A., Jeste D.V. The neurobiology of neuropsychiatric syndromes in dementia. Curr. Opin. Psychiatry 2006, 19:581-586.
157. Meyer U., Feldon J., Yee B.K. A review of the fetal brain cytokine imbalance hypothesis of schizophrenia. Schizophr. Bull. 2009, 35:959-972.
158. Meyer U., Nyffeler M., Yee B.K., Knuesel I., Feldon J. Adult brain and behavioral pathological markers of prenatal immune challenge during early/middle and late fetal development in mice. Brain Behav. Immun. 2008, 22:469-486.
159. Meyer U., Nyffeler M., Schwendener S., Knuesel I., Yee B.K., Feldon J. Relative prenatal and postnatal maternal contributions to schizophrenia-related neurochemical dysfunction after in utero immune challenge. Neuropsychopharmacology 2008, 33:441-456.
160. Meyer U., Nyffeler M., Engler A., Urwyler A., Schedlowski M., Knuesel I., Yee B.K., Feldon J. The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. J. Neurosci. 2006, 26:4752-4762.
161. Miettinen R., Riedel A., Kalesnykas G., Kettunen H.P., Puolivali J., Soininen H., Arendt T. Reelin-immunoreactivity in the hippocampal formation of 9-month-old wildtype mouse: effects of APP/PS1 genotype and ovariectomy. J. Chem. Neuroanat. 2005, 30:105-118.
162. Miyata T., Nakajima K., Mikoshiba K., Ogawa M. Regulation of Purkinje cell alignment by reelin as revealed with CR-50 antibody. J. Neurosci. 1997, 17:3599-3609.
163. Miyoshi K., Honda A., Baba K., Taniguchi M., Oono K., Fujita T., Kuroda S., Katayama T., Tohyama M. Disrupted-in-schizophrenia 1, a candidate gene for schizophrenia, participates in neurite outgrowth. Mol. Psychiatry 2003, 8:685-694.
164. Morimura T., Hattori M., Ogawa M., Mikoshiba K. Disabled1 regulates the intracellular trafficking of reelin receptors. J. Biol. Chem. 2005, 280:16901-16908.
165. Motoi Y., Itaya M., Mori H., Mizuno Y., Iwasaki T., Hattori H., Haga S., Ikeda K. Apolipoprotein E receptor 2 is involved in neuritic plaque formation in APP sw mice. Neurosci. Lett. 2004, 368:144-147.
166. Mrak R.E., Griffin W.S. Glia and their cytokines in progression of neurodegeneration. Neurobiol. Aging 2005, 26:349-354.
167. Muller M.C., Osswald M., Tinnes S., Haussler U., Jacobi A., Forster E., Frotscher M., Haas C.A. Exogenous reelin prevents granule cell dispersion in experimental epilepsy. Exp. Neurol. 2009, 216:390-397.
168. Nakajima K., Mikoshiba K., Miyata T., Kudo C., Ogawa M. Disruption of hippocampal development in vivo by CR-50 mAb against reelin. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:8196-8201.
169. Nakano Y., Kohno T., Hibi T., Kohno S., Baba A., Mikoshiba K., Nakajima K., Hattori M. The extremely conserved C-terminal region of Reelin is not necessary for secretion but is required for efficient activation of downstream signaling. J. Biol. Chem. 2007, 282:20544-20552.
170. Niizato K., Genda K., Nakamura R., Iritani S., Ikeda K. Cognitive decline in schizophrenics with Alzheimer's disease: a mini-review of neuropsychological and neuropathological studies. Prog. Neuropsychopharmacol. Biol. Psychiatry 2001, 25:1359-1366.
171. Nikolaev A., McLaughlin T., O'Leary D.D., Tessier-Lavigne M. APP binds DR6 to trigger axon pruning and neuron death via distinct caspases. Nature 2009, 457:981-989.
172. Niu S., Yabut O., D'Arcangelo G. The Reelin signaling pathway promotes dendritic spine development in hippocampal neurons. J. Neurosci. 2008, 28:10339-10348.
173. Niu S., Renfro A., Quattrocchi C.C., Sheldon M., D'Arcangelo G. Reelin promotes hippocampal dendrite development through the VLDLR/ApoER2-Dab1 pathway. Neuron 2004, 41:71-84.
174. Nyffeler M., Meyer U., Yee B.K., Feldon J., Knuesel I. Maternal immune activation during pregnancy increases limbic GABA(A) receptor immunoreactivity in the adult offspring: implications for schizophrenia. Neuroscience 2006, 143:51-62.
175. Ogawa M., Miyata T., Nakajima K., Yagyu K., Seike M., Ikenaka K., Yamamoto H., Mikoshiba K. The reeler gene-associated antigen on Cajal-Retzius neurons is a crucial molecule for laminar organization of cortical neurons. Neuron 1995, 14:899-912.
176. Ohkubo N., Lee Y.D., Morishima A., Terashima T., Kikkawa S., Tohyama M., Sakanaka M., Tanaka J., Maeda N., Vitek M.P., Mitsuda N. Apolipoprotein E and Reelin ligands modulate tau phosphorylation through an apolipoprotein E receptor/disabled-1/glycogen synthase kinase-3beta cascade. FASEB J. 2003, 17:295-297.
177. Oken R.J., McGeer P.L. Schizophrenia, Alzheimer's disease, and anti-inflammatory agents. Schizophr. Bull. 1996, 22:1-4.
178. Pappas G.D., Kriho V., Liu W.S., Tremolizzo L., Lugli G., Larson J. Immunocytochemical localization of reelin in the olfactory bulb of the heterozygous reeler mouse: an animal model for schizophrenia. Neurol. Res. 2003, 25:819-830.
179. Parachikova A., Agadjanyan M.G., Cribbs D.H., Blurton-Jones M., Perreau V., Rogers J., Beach T.G., Cotman C.W. Inflammatory changes parallel the early stages of Alzheimer disease. Neurobiol. Aging 2007, 28:1821-1833.
180. Parisiadou L., Efthimiopoulos S. Expression of mDab1 promotes the stability and processing of amyloid precursor protein and this effect is counteracted by X11alpha. Neurobiol. Aging 2007, 28:377-388.
181. Pascual M., Perez-Sust P., Soriano E. The GABAergic septohippocampal pathway in control and reeler mice: target specificity and termination onto Reelin-expressing interneurons. Mol. Cell. Neurosci. 2004, 25:679-691.
182. Patterson P.H. Neuroscience. Maternal effects on schizophrenia risk. Science 2007, 318:576-577.
183. Persico A.M., Levitt P., Pimenta A.F. Polymorphic GGC repeat differentially regulates human reelin gene expression levels. J. Neural Transm. 2006, 113:1373-1382.
184. Persico A.M., D'Agruma L., Maiorano N., Totaro A., Militerni R., Bravaccio C., Wassink T.H., Schneider C., Melmed R., Trillo S., Montecchi F., Palermo M., Pascucci T., Puglisi-Allegra S., Reichelt K.L., Conciatori M., Marino R., Quattrocchi C.C., Baldi A., Zelante L., Gasparini P., Keller F. Reelin gene alleles and haplotypes as a factor predisposing to autistic disorder. Mol. Psychiatry 2001, 6:150-159.
185. Pesold C., Impagnatiello F., Pisu M.G., Uzunov D.P., Costa E., Guidotti A., Caruncho H.J. Reelin is preferentially expressed in neurons synthesizing gamma-aminobutyric acid in cortex and hippocampus of adult rats. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:3221-3226.
186. Powchik P., Davidson M., Haroutunian V., Gabriel S.M., Purohit D.P., Perl D.P., Harvey P.D., Davis K.L. Postmortem studies in schizophrenia. Schizophr. Bull. 1998, 24:325-341.
187. Pramatarova A., Ochalski P.G., Chen K., Gropman A., Myers S., Min K.T., Howell B.W. Nck beta interacts with tyrosine-phosphorylated disabled 1 and redistributes in Reelin-stimulated neurons. Mol. Cell. Biol. 2003, 23:7210-7221.
188. Prohovnik I., Dwork A.J., Kaufman M.A., Willson N. Alzheimer-type neuropathology in elderly schizophrenia patients. Schizophr. Bull. 1993, 19:805-816.
189. Qiu S., Weeber E.J. Reelin signaling facilitates maturation of CA1 glutamatergic synapses. J. Neurophysiol. 2007, 97:2312-2321.
190. Qiu S., Korwek K.M., Weeber E.J. A fresh look at an ancient receptor family: emerging roles for low density lipoprotein receptors in synaptic plasticity and memory formation. Neurobiol. Learn. Mem. 2006, 85:16-29.
191. Qiu S., Zhao L.F., Korwek K.M., Weeber E.J. Differential reelin-induced enhancement of NMDA and AMPA receptor activity in the adult hippocampus. J. Neurosci. 2006, 26:12943-12955.
192. Qiu S., Korwek K.M., Pratt-Davis A.R., Peters M., Bergman M.Y., Weeber E.J. Cognitive disruption and altered hippocampus synaptic function in Reelin haploinsufficient mice. Neurobiol. Learn. Mem. 2006, 85:228-242.
193. Quintanilla R.A., Orellana D.I., Gonzalez-Billault C., Maccioni R.B. Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5/p35 pathway. Exp. Cell Res. 2004, 295:245-257.
194. Rakic P., Caviness V.S. Cortical development: view from neurological mutants two decades later. Neuron 1995, 14:1101-1104.
195. Ramos-Moreno T., Galazo M.J., Porrero C., Martinez-Cerdeno V., Clasca F. Extracellular matrix molecules and synaptic plasticity: immunomapping of intracellular and secreted Reelin in the adult rat brain. Eur. J. Neurosci. 2006, 23:401-422.
196. Rapoport J.L., Addington A.M., Frangou S., Psych M.R. The neurodevelopmental model of schizophrenia: update 2005. Mol. Psychiatry 2005, 10:434-449.
197. Reeves R.R., Brister J.C. Psychosis in late life: emerging issues. J. Psychosoc. Nurs. Ment. Health Serv. 2008, 46:45-52.
198. Religa D., Laudon H., Styczynska M., Winblad B., Naslund J., Haroutunian V. Amyloid beta pathology in Alzheimer's disease and schizophrenia. Am. J. Psychiatry 2003, 160:867-872.
199. Rice D.S., Curran T. Role of the reelin signaling pathway in central nervous system development. Annu. Rev. Neurosci. 2001, 24:1005-1039.
200. Riddell D.R., Zhou H., Atchison K., Warwick H.K., Atkinson P.J., Jefferson J., Xu L., Aschmies S., Kirksey Y., Hu Y., Wagner E., Parratt A., Xu J., Li Z., Zaleska M.M., Jacobsen J.S., Pangalos M.N., Reinhart P.H. Impact of apolipoprotein E (ApoE) polymorphism on brain ApoE levels. J. Neurosci. 2008, 28:11445-11453.
201. Riedel A., Miettinen R., Stieler J., Mikkonen M., Alafuzoff I., Soininen H., Arendt T. Reelin-immunoreactive Cajal-Retzius cells: the entorhinal cortex in normal aging and Alzheimer's disease. Acta Neuropathol. (Berl.) 2003, 106:291-302.
202. Roberts R.C., Roche J.K., Conley R.R. Differential synaptic changes in the striatum of subjects with undifferentiated versus paranoid schizophrenia. Synapse 2008, 62:616-627.
203. Roberts R.C., Xu L., Roche J.K., Kirkpatrick B. Ultrastructural localization of reelin in the cortex in post-mortem human brain. J. Comp. Neurol. 2005, 482:294-308.
204. Rogaev E.I., Sherrington R., Rogaeva E.A., Levesque G., Ikeda M., Liang Y., Chi H., Lin C., Holman K., Tsuda T., et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 1995, 376:775-778.
205. Royaux I., Lambert de Rouvroit C., D'Arcangelo G., Demirov D., Goffinet A.M. Genomic organization of the mouse reelin gene. Genomics 1997, 46:240-250.
206. Ruzicka W.B., Zhubi A., Veldic M., Grayson D.R., Costa E., Guidotti A. Selective epigenetic alteration of layer I GABAergic neurons isolated from prefrontal cortex of schizophrenia patients using laser-assisted microdissection. Mol. Psychiatry 2007, 12:385-397.
207. Saez-Valero J., Costell M., Sjogren M., Andreasen N., Blennow K., Luque J.M. Altered levels of cerebrospinal fluid reelin in frontotemporal dementia and Alzheimer's disease. J. Neurosci. Res. 2003, 72:132-136.
208. Salminen A., Ojala J., Kauppinen A., Kaarniranta K., Suuronen T. Inflammation in Alzheimer's disease: amyloid-beta oligomers trigger innate immunity defence via pattern recognition receptors. Prog. Neurobiol. 2009, 87:181-194.
209. Sarkar D., Fisher P.B. Molecular mechanisms of aging-associated inflammation. Cancer Lett. 2006, 236:13-23.
210. Savla G.N., Palmer B.W. Neuropsychology in Alzheimer's disease and other dementia research. Curr. Opin. Psychiatry 2005, 18:621-627.
211. Schmechel D.E., Saunders A.M., Strittmatter W.J., Crain B.J., Hulette C.M., Joo S.H., Pericak-Vance M.A., Goldgaber D., Roses A.D. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:9649-9653.
212. Segal M. Rapid plasticity of dendritic spine: hints to possible functions?. Prog. Neurobiol. 2001, 63:61-70.
213. Senzaki K., Ogawa M., Yagi T. Proteins of the CNR family are multiple receptors for Reelin. Cell 1999, 99:635-647.
214. Serantes R., Arnalich F., Figueroa M., Salinas M., Andres-Mateos E., Codoceo R., Renart J., Matute C., Cavada C., Cuadrado A., Montiel C. Interleukin-1beta enhances GABAA receptor cell-surface expression by a phosphatidylinositol 3-kinase/Akt pathway: relevance to sepsis-associated encephalopathy. J. Biol. Chem. 2006, 281:14632-14643.
215. Seripa D., Matera M.G., Franceschi M., Daniele A., Bizzarro A., Rinaldi M., Panza F., Fazio V.M., Gravina C., D'Onofrio G., Solfrizzi V., Masullo C., Pilotto A. The RELN locus in Alzheimer's disease. J. Alzheimers Dis. 2008, 14:335-344.
216. Sheng J.G., Mrak R.E., Griffin W.S. Microglial interleukin-1 alpha expression in brain regions in Alzheimer's disease: correlation with neuritic plaque distribution. Neuropathol. Appl. Neurobiol. 1995, 21:290-301.
217. Sheng J.G., Zhu S.G., Jones R.A., Griffin W.S., Mrak R.E. Interleukin-1 promotes expression and phosphorylation of neurofilament and tau proteins in vivo. Exp. Neurol. 2000, 163:388-391.
218. Sheng J.G., Ito K., Skinner R.D., Mrak R.E., Rovnaghi C.R., Van Eldik L.J., Griffin W.S. In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis. Neurobiol. Aging 1996, 17:761-766.
219. Sheng J.G., Jones R.A., Zhou X.Q., McGinness J.M., Van Eldik L.J., Mrak R.E., Griffin W.S. Interleukin-1 promotion of MAPK-p38 overexpression in experimental animals and in Alzheimer's disease: potential significance for tau protein phosphorylation. Neurochem. Int. 2001, 39:341-348.
220. Sherrington R., Rogaev E.I., Liang Y., Rogaeva E.A., Levesque G., Ikeda M., Chi H., Lin C., Li G., Holman K., et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995, 375:754-760.
221. Shifman S., Johannesson M., Bronstein M., Chen S.X., Collier D.A., Craddock N.J., Kendler K.S., Li T., O'Donovan M., O'Neill F.A., Owen M.J., Walsh D., Weinberger D.R., Sun C., Flint J., Darvasi A. Genome-wide association identifies a common variant in the reelin gene that increases the risk of schizophrenia only in women. PLoS Genet. 2008, 4:e28.
222. Shu T., Ayala R., Nguyen M.D., Xie Z., Gleeson J.G., Tsai L.H. Ndel1 operates in a common pathway with LIS1 and cytoplasmic dynein to regulate cortical neuronal positioning. Neuron 2004, 44:263-277.
223. Sinagra M., Gonzalez Campo C., Verrier D., Moustie O., Manzoni O.J., Chavis P. Glutamatergic cerebellar granule neurons synthesize and secrete reelin in vitro. Neuron Glia Biol. 2008, 4:189-196.
224. Sinagra M., Verrier D., Frankova D., Korwek K.M., Blahos J., Weeber E.J., Manzoni O.J., Chavis P. Reelin, very-low-density lipoprotein receptor, and apolipoprotein E receptor 2 control somatic NMDA receptor composition during hippocampal maturation in vitro. J. Neurosci. 2005, 25:6127-6136.
225. Soustek Z. Ultrastructure of cortical synapses in the brain of schizophrenics. Zentralbl. Allg. Pathol. 1989, 135:25-32.
226. Stewart W.F., Kawas C., Corrada M., Metter E.J. Risk of Alzheimer's disease and duration of NSAID use. Neurology 1997, 48:626-632.
227. Stockinger W., Brandes C., Fasching D., Hermann M., Gotthardt M., Herz J., Schneider W.J., Nimpf J. The reelin receptor ApoER2 recruits JNK-interacting proteins-1 and -2. J. Biol. Chem. 2000, 275:25625-25632.
228. Strasser V., Fasching D., Hauser C., Mayer H., Bock H.H., Hiesberger T., Herz J., Weeber E.J., Sweatt J.D., Pramatarova A., Howell B., Schneider W.J., Nimpf J. Receptor clustering is involved in Reelin signaling. Mol. Cell. Biol. 2004, 24:1378-1386.
229. Suetsugu S., Tezuka T., Morimura T., Hattori M., Mikoshiba K., Yamamoto T., Takenawa T. Regulation of actin cytoskeleton by mDab1 through N-WASP and ubiquitination of mDab1. Biochem. J. 2004, 384:1-8.
230. Sullivan R., Wilson D.A., Feldon J., Yee B.K., Meyer U., Richter-Levin G., Avi A., Michael T., Gruss M., Bock J., Helmeke C., Braun K. The International Society for Developmental Psychobiology annual meeting symposium: impact of early life experiences on brain and behavioral development. Dev. Psychobiol. 2006, 48:583-602.
231. Sun D., Phillips L., Velakoulis D., Yung A., McGorry P.D., Wood S.J., van Erp T.G., Thompson P.M., Toga A.W., Cannon T.D., Pantelis C. Progressive brain structural changes mapped as psychosis develops in 'at risk' individuals. Schizophr. Res. 2009, 108:85-92.
232. Tissir F., Goffinet A.M. Reelin and brain development. Nat. Rev. Neurosci. 2003, 4:496-505.
233. Tochigi M., Iwamoto K., Bundo M., Komori A., Sasaki T., Kato N., Kato T. Methylation status of the reelin promoter region in the brain of schizophrenic patients. Biol. Psychiatry 2008, 63:530-533.
234. Trommsdorff M., Borg J.P., Margolis B., Herz J. Interaction of cytosolic adaptor proteins with neuronal apolipoprotein E receptors and the amyloid precursor protein. J. Biol. Chem. 1998, 273:33556-33560.
235. Trommsdorff M., Gotthardt M., Hiesberger T., Shelton J., Stockinger W., Nimpf J., Hammer R.E., Richardson J.A., Herz J. Reeler/Disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2. Cell 1999, 97:689-701.
236. Tueting P., Costa E., Dwivedi Y., Guidotti A., Impagnatiello F., Manev R., Pesold C. The phenotypic characteristics of heterozygous reeler mouse. Neuroreport 1999, 10:1329-1334.
237. Urosevic N., Martins R.N. Infection and Alzheimer's disease: the APOE epsilon4 connection and lipid metabolism. J. Alzheimers Dis. 2008, 13:421-435.
238. Utsunomiya-Tate N., Kubo K., Tate S., Kainosho M., Katayama E., Nakajima K., Mikoshiba K. Reelin molecules assemble together to form a large protein complex, which is inhibited by the function-blocking CR-50 antibody. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:9729-9734.
239. Veldic M., Caruncho H.J., Liu W.S., Davis J., Satta R., Grayson D.R., Guidotti A., Costa E. DNA-methyltransferase 1 mRNA is selectively overexpressed in telencephalic GABAergic interneurons of schizophrenia brains. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:348-353.
240. von Rotz R.C., Kohli B.M., Bosset J., Meier M., Suzuki T., Nitsch R.M., Konietzko U. The APP intracellular domain forms nuclear multiprotein complexes and regulates the transcription of its own precursor. J. Cell. Sci. 2004, 117:4435-4448.
241. Walker D., Lue L.F. Anti-inflammatory and immune therapy for Alzheimer's disease: current status and future directions. Curr. Neuropharmacol. 2007, 5:232-243.
242. Walsh D.M., Klyubin I., Fadeeva J.V., Rowan M.J., Selkoe D.J. Amyloid-beta oligomers: their production, toxicity and therapeutic inhibition. Biochem. Soc. Trans. 2002, 30:552-557.
243. Wang S.C., Oelze B., Schumacher A. Age-specific epigenetic drift in late-onset Alzheimer's disease. PLoS ONE 2008, 3:e2698.
244. Weeber E.J., Beffert U., Jones C., Christian J.M., Forster E., Sweatt J.D., Herz J. Reelin and ApoE receptors cooperate to enhance hippocampal synaptic plasticity and learning. J. Biol. Chem. 2002, 277:39944-39952.
245. Weinberger D.R. Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiatry 1987, 44:660-669.
246. Wirths O., Multhaup G., Czech C., Blanchard V., Tremp G., Pradier L., Beyreuther K., Bayer T.A. Reelin in plaques of beta-amyloid precursor protein and presenilin-1 double-transgenic mice. Neurosci. Lett. 2001, 316:145-148.
247. Wu J., Basha M.R., Zawia N.H. The environment, epigenetics and amyloidogenesis. J. Mol. Neurosci. 2008, 34:1-7.
248. Wyss-Coray T. Inflammation in Alzheimer disease: driving force, bystander or beneficial response?. Nat. Med. 2006, 12:1005-1015.
249. Xu Q., Bernardo A., Walker D., Kanegawa T., Mahley R.W., Huang Y. Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus. J. Neurosci. 2006, 26:4985-4994.
250. Yamamoto M., Kiyota T., Horiba M., Buescher J.L., Walsh S.M., Gendelman H.E., Ikezu T. Interferon-gamma and tumor necrosis factor-alpha regulate amyloid-beta plaque deposition and beta-secretase expression in Swedish mutant APP transgenic mice. Am. J. Pathol. 2007, 170:680-692.
251. Young-Pearse T.L., Bai J., Chang R., Zheng J.B., LoTurco J.J., Selkoe D.J. A critical function for beta-amyloid precursor protein in neuronal migration revealed by in utero RNA interference. J. Neurosci. 2007, 27:14459-14469.
252. Zawia N.H., Lahiri D.K., Cardozo-Pelaez F. Epigenetics, oxidative stress, and Alzheimer disease. Free Radic. Biol. Med. 2009, 46:1241-1249.
253. Zhao L., Lin S., Bales K.R., Gelfanova V., Koger D., Delong C., Hale J., Liu F., Hunter J.M., Paul S.M. Macrophage-mediated degradation of beta-amyloid via an apolipoprotein E isoform-dependent mechanism. J. Neurosci. 2009, 29:3603-3612.